Posted in Antibodies, Assay Kits, Biology Cells, cDNA, Clia Kits, Culture Cells, Devices, DNA, DNA Templates, DNA Testing, Elisa Kits, Enzymes, Equipments, Exosomes, Gels, Isotypes, Medium & Serums, Panel, Particles, PCR, Pcr Kits, Peptides, Reagents, Recombinant Proteins, Ria Kits, RNA, Test Kits, Uncategorized, Vector & Virus
Decrease in serum alkaline phosphatase and prognostic relevance in adult cardiopulmonary bypass
Objective: Cardiopulmonary bypass (CPB) induces an inflammatory response, which can cause loss of alkaline phosphatase (AP) consumed in the process of extracellular nucleotides dephosphorylating disadvantage in this proinflammatory state. It has been reported that the rate of postoperative low AP correlated with increased support needs post surgery and organ dysfunction after pediatric cardiac surgery. However, little is known about the development of perioperative and clinical relevance of depletion AP in adults undergoing CPB.
Methods: A total of 183 patients with left ventricular ejection fraction ≤50% preoperatively underwent mitral valve surgery ± concurrent procedure related in the Department of Cardiac Surgery, Medical University of Vienna, between 2013 and 2016 were included in this retrospective analysis. AP serum measurements at baseline and at days 1-15 post surgery were collected. AP absolute and relative reduction in postoperative day 1 of baseline parameters correlated with perioperative and postoperative early. Receiver operating characteristics used to determine predictors fit and cut-off for postoperative outcome variables.
Results: The operating characteristics Receiver showed a decrease of> 50% of the base AP to predict in-hospital mortality [area under the curve (AUC) 0.807], prolonged intensive care unit stay (> 72 hours, AUC 0.707), mechanical ventilation prolonged (> 24 hours, AUC 0.712) and need for dialysis-related operasi- (AUC 0.736). Patients with perioperative decrease in circulating AP to levels below 50% of the base has significantly decreased survival. Patients with high loss of perioperative AP AP preoperative levels of higher (P <0.001), longer duration of CPB (P <0.001) and a higher incidence of lung artificial support (P <0.001).
Conclusion: Increased perioperative AP loss associated with early adverse outcomes. prospective trial is needed to determine whether this effect can be neutralized by AP perioperative supplementation.
Difference Serum Alkaline Phosphatase Levels in Infants with spontaneous intestinal perforation compared Necrotizing enterocolitis with perforation
Introduction: Data laboratory markers spontaneous intestinal perforation (SIP) and necrotizing enterocolitis (NEC) remains sparse.
Objective: To compare serum levels of alkaline phosphatase in infants with intestinal perforation secondary to SIP vs NEC surgery, and then investigate the possible role of serum alkaline phosphatase to distinguish infants with this condition.
Methods: A retrospective case-control study of infants admitted with bowel perforation from 2005 to 2015. Demographics and Data prenatal, postnatal exposure, and clinical, laboratory, and radiographic findings were drawn from inpatient medical records and analyzed using regression analysis.
p38 |
MBS8533658-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
p38 |
MBS8533658-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
p38 |
MBS8533658-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
p38 MAPK |
E8ET1702-65 |
EnoGene |
100ul |
EUR 275 |
Description: Available in various conjugation types. |
Mxi2, p38 |
MBS603655-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3530 |
p38 MAPK |
MBS8534372-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
p38 MAPK |
MBS8534372-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
p38 MAPK |
MBS8534372-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
p38 MAPK |
MBS8534372-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
p38 protein |
E20-80078 |
EnoGene |
20ug |
EUR 275 |
Description: N/A |
p38 protein |
E20-80079 |
EnoGene |
20ug |
EUR 275 |
Description: N/A |
p38 protein |
MBS8526800-002mg |
MyBiosource |
0.02mg |
EUR 345 |
p38 protein |
MBS8526800-5x002mg |
MyBiosource |
5x0.02mg |
EUR 1410 |
p38 protein |
MBS8526801-002mg |
MyBiosource |
0.02mg |
EUR 345 |
p38 protein |
MBS8526801-5x002mg |
MyBiosource |
5x0.02mg |
EUR 1410 |
p38 Antibody |
20-abx007541 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
p38 antibody |
70R-51505 |
Fitzgerald |
100 ul |
EUR 242 |
|
Description: Purified Polyclonal p38 antibody |
p38 antibody |
70R-51506 |
Fitzgerald |
100 ul |
EUR 286 |
|
Description: Purified Polyclonal p38 antibody |
p38 Antibody |
35478 |
SAB |
100ul |
EUR 479 |
p38 Antibody |
35478-100ul |
SAB |
100ul |
EUR 468 |
p38 Antibody |
20-abx133223 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
p38 Antibody |
48644 |
SAB |
100ul |
EUR 499 |
p38 Antibody |
48644-100ul |
SAB |
100ul |
EUR 399.6 |
p38 Antibody |
48644-50ul |
SAB |
50ul |
EUR 286.8 |
p38 Antibody |
20-abx141038 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
p38 Antibody |
B7178-100ul |
Assay Biotech |
100μl |
EUR 217 |
Description: p38 Rabbit Polyclonal Antibody |
p38 Antibody |
B7178-50ul |
Assay Biotech |
50μl |
EUR 143.5 |
Description: p38 Rabbit Polyclonal Antibody |
p38 Antibody |
B0798-100ul |
Assay Biotech |
100μl |
EUR 217 |
Description: p38 Rabbit Polyclonal Antibody |
p38 Antibody |
B0798-50ul |
Assay Biotech |
50μl |
EUR 143.5 |
Description: p38 Rabbit Polyclonal Antibody |
p38 Antibody |
B0799-100ul |
Assay Biotech |
100μl |
EUR 217 |
Description: p38 Rabbit Polyclonal Antibody |
p38 Antibody |
B0799-50ul |
Assay Biotech |
50μl |
EUR 143.5 |
Description: p38 Rabbit Polyclonal Antibody |
p38 Antibody |
abx236076-100g |
Abbexa |
100 µg |
EUR 350 |
p38 Antibody |
abx236076-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
p38 Antibody |
E38PA4721 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
p38 Antibody |
E38PA5060 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
p38 Antibody |
E38PA5094 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
p38 Antibody |
E38PA7126 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
p38 Antibody |
E38PA3186 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
p38 Antibody |
MBS5316121-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1920 |
p38 Antibody |
MBS5316122-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2270 |
p38 Antibody |
MBS8002013-0025mL |
MyBiosource |
0.025mL |
EUR 315 |
p38 Antibody |
MBS8002013-5x0025mL |
MyBiosource |
5x0.025mL |
EUR 890 |
p38 Antibody |
MBS805089-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1350 |
p38 Antibody |
MBS806203-0025mL |
MyBiosource |
0.025mL |
EUR 320 |
p38 Antibody |
MBS8581787-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
p38 Antibody |
MBS8581787-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
p38 Antibody |
MBS8581787-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
p38 Antibody |
MBS8581787-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
p38 Antibody |
MBS8584173-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
p38 Antibody |
MBS8584173-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
p38 Antibody |
MBS8584173-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
p38 Antibody |
MBS8584173-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
p38 Antibody |
MBS8582665-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
p38 Antibody |
MBS8582665-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
p38 Antibody |
MBS8582665-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
p38 Antibody |
MBS8582665-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
p38 Antibody |
MBS8582905-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
p38 Antibody |
MBS8582905-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
p38 Antibody |
MBS8582905-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
p38 Antibody |
MBS8582905-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
p38 Antibody |
MBS8582923-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
p38 Antibody |
MBS8582923-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
p38 Antibody |
MBS8582923-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
p38 Antibody |
MBS8582923-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
p38 Antibody |
MBS9508977-005mL |
MyBiosource |
0.05mL |
EUR 285 |
p38 Antibody |
MBS9508977-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1590 |
p38 Antibody |
MBS9409774-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1740 |
p38 Antibody |
MBS9435492-005mL |
MyBiosource |
0.05mL |
EUR 325 |
p38 Antibody |
MBS9435492-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1810 |
p38 Antibody |
SPC-172D |
Stressmarq |
0.1ml |
EUR 161 |
Description: Rabbit Anti-Human p38 Polyclonal |
p38 Antibody |
SPC-172S |
Stressmarq |
0.012ml |
Ask for price |
Description: Rabbit Anti-Human p38 Polyclonal |
p38 Substrate |
MBS517838-5x1mg |
MyBiosource |
5x1mg |
EUR 675 |
MAP Kinase p38, Control Cell Extracts (Mitogen Activated Protein Kinase p38, MAPK p38) |
MBS657552-10Blots |
MyBiosource |
10Blots |
EUR 430 |
MAP Kinase p38, Control Cell Extracts (Mitogen Activated Protein Kinase p38, MAPK p38) |
MBS657552-5x10Blots |
MyBiosource |
5x10Blots |
EUR 1785 |
MAP Kinase p38, phosphorylated (Thr180, Ty182) (Mitogen Activated Protein Kinase p38, MAPK p38) |
MBS633592-01mL |
MyBiosource |
0.1mL |
EUR 695 |
MAP Kinase p38, phosphorylated (Thr180, Ty182) (Mitogen Activated Protein Kinase p38, MAPK p38) |
MBS633592-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2985 |
MAP Kinase p38, phosphorylated (Thr180, Ty182) (Mitogen Activated Protein Kinase p38, MAPK p38) |
MBS632290-02mL |
MyBiosource |
0.2mL |
EUR 660 |
MAP Kinase p38, phosphorylated (Thr180, Ty182) (Mitogen Activated Protein Kinase p38, MAPK p38) |
MBS632290-5x02mL |
MyBiosource |
5x0.2mL |
EUR 2810 |
MAP Kinase p38, phosphorylated (Thr180, Tyr182) (Mitogen Activated Protein Kinase p38, MAPK p38) |
MBS630803-02mL |
MyBiosource |
0.2mL |
EUR 650 |
MAP Kinase p38, phosphorylated (Thr180, Tyr182) (Mitogen Activated Protein Kinase p38, MAPK p38) |
MBS630803-06mL |
MyBiosource |
0.6mL |
EUR 1175 |
MAP Kinase p38, phosphorylated (Thr180, Tyr182) (Mitogen Activated Protein Kinase p38, MAPK p38) |
MBS630803-5x06mL |
MyBiosource |
5x0.6mL |
EUR 5140 |
MAP Kinase p38, phosphorylated (Thr180, Tyr182) (Mitogen Activated Protein Kinase p38, MAPK p38) |
MBS627818-10Blots |
MyBiosource |
10Blots |
EUR 875 |
MAP Kinase p38, phosphorylated (Thr180, Tyr182) (Mitogen Activated Protein Kinase p38, MAPK p38) |
MBS627818-5x10Blots |
MyBiosource |
5x10Blots |
EUR 3785 |
SB-203580 p38 MAPK(p38 MAP kinase) Inhibitor |
E1B1863 |
EnoGene |
1mg |
EUR 85 |
SB-203580 p38 MAPK (p38 MAP kinase) Inhibitor |
MBS8579825-1mg |
MyBiosource |
1mg |
EUR 180 |
SB-203580 p38 MAPK (p38 MAP kinase) Inhibitor |
MBS8579825-5x1mg |
MyBiosource |
5x1mg |
EUR 660 |
p38 (411-425) M.leprae |
MBS8246858-10mg |
MyBiosource |
10mg |
EUR 675 |
p38 (411-425) M.leprae |
MBS8246858-1mg |
MyBiosource |
1mg |
EUR 255 |
p38 (411-425) M.leprae |
MBS8246858-5mg |
MyBiosource |
5mg |
EUR 480 |
p38 (411-425) M.leprae |
MBS8246858-5x10mg |
MyBiosource |
5x10mg |
EUR 2955 |
MAP Kinase p38, phosphorylated (Thr180, Ty182) (Mitogen Activated Protein Kinase p38, MAPK p38) (Agarose) |
MBS631660-04mL |
MyBiosource |
0.4mL |
EUR 670 |
MAP Kinase p38, phosphorylated (Thr180, Ty182) (Mitogen Activated Protein Kinase p38, MAPK p38) (Agarose) |
MBS631660-5x04mL |
MyBiosource |
5x0.4mL |
EUR 2870 |
Anti - p38-a |
MBS684252-002mL |
MyBiosource |
0.02mL |
EUR 270 |
Anti - p38-a |
MBS684252-005mL |
MyBiosource |
0.05mL |
EUR 485 |
Anti - p38-a |
MBS684252-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2925 |
Anti - p38-b |
MBS684253-002mL |
MyBiosource |
0.02mL |
EUR 270 |
Anti - p38-b |
MBS684253-005mL |
MyBiosource |
0.05mL |
EUR 485 |
Anti - p38-b |
MBS684253-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2925 |
Anti - p38-g |
MBS684254-002mL |
MyBiosource |
0.02mL |
EUR 270 |
Anti - p38-g |
MBS684254-005mL |
MyBiosource |
0.05mL |
EUR 485 |
Anti - p38-g |
MBS684254-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2925 |
Anti - p38-d |
MBS684255-002mL |
MyBiosource |
0.02mL |
EUR 270 |
Anti - p38-d |
MBS684255-005mL |
MyBiosource |
0.05mL |
EUR 485 |
Anti - p38-d |
MBS684255-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2925 |
p38 Mouse mAb |
E2220879 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
p38 Mouse mAb |
E2222580 |
EnoGene |
100ul |
EUR 255 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
p38 Mouse mAb |
MBS8539086-01mL |
MyBiosource |
0.1mL |
EUR 305 |
p38 Mouse mAb |
MBS8539086-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
p38 Mouse mAb |
MBS8539086-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
p38 Mouse mAb |
MBS8539086-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
p38 Mouse mAb |
MBS8539086-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
p38 Rabbit pAb |
E2340697 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
p38 Rabbit pAb |
E2380881 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
p38 Rabbit pAb |
E2381051 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
Results: Of the 114 infants included outborn, 48 babies have SIP (cases) and 66 have NEC (control). Upon entry of the hospital refers, serum alkaline phosphatase levels were significantly higher in infants with SIP, ie, the median value of versus236 782 U / L in patients with NEC (p <0.0001), with an adjusted odds ratio (OR) of 4.3 (p <0.05) when the level is> 500 U / L in a multivariate regression model. Infants with gestational age SIP has significantly younger, presented earlier in life, especially with pneumoperitoneum, and have a greater exposure to steroids and indomethacin compared infants with NEC. alkaline phosphatase levels decreased rapidly in infants with the following SIP entry.
Conclusion: A temporary increase in serum alkaline phosphatase levels were independently associated with SIP when compared to the NEC. Studies confirm the role of alkaline phosphatase in the diagnosis of the necessary SIP and has clinical implications and potential prognostic significance.